Skip to content

The Effect of Continuous Accompanying Support in the Active Phase on Labor Pain, Duration and Satisfaction

The Effect of Continuous Accompanying Support in the Active Phase on Labor Pain, Duration and Satisfaction

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05720962
Enrollment
110
Registered
2023-02-09
Start date
2023-01-01
Completion date
2024-03-01
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Continuous Birth Support

Keywords

continuous birth support, birth time, labor pain, satisfaction

Brief summary

This study was planned to determine the effect of continuous accompanying support during the active phase on labor pain, duration and satisfaction.

Detailed description

Participants who comes into childbirth needs the support of people around her in order to cope with the stress, anxiety and labor pain she experiences. This support is the continuous birth support given from the time the participants comes to the hospital until the birth of the baby. Having someone who supports the woman during the birth process will provide a positive birth experience for pregnant women. At the same time, the feeling of pain of the supported woman will be reduced and the delivery time will be shortened. This randomized controlled study was planned to be performed on primiparous pregnant women between January 2023 and January 2024. The data of the study will be collected with Personal Information Form, Visual Analog Scale. The study was divided into two groups as experimental and control groups. 55 participants in the experiment -55 participants will be randomized to the control group. Participants meeting the inclusion criteria will be asked to rate their pain and satisfaction from 0 to 10 with the VAS 4 cm, 6 cm, 8 cm and fully open. While both groups receive routine midwife support, when the experimental group reaches 4 cm, a person they want will be taken with them and continuous support will be given until there is a dilation of 10 cm.

Interventions

PROCEDUREuninterrupted accompanying support

When the participants in the experimental group are taken to the delivery unit, when the neck dilation is 4 cm, a person they want will be taken with them to support them. Afterwards, the pain status and satisfaction of the participants will be questioned when it is 4 cm, 6 cm, 8 cm and 10 cm.

Sponsors

Istanbul University - Cerrahpasa
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

randomized controlled study with two groups as control and experimental group

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-35 years old * Being literate * Fluent and speaking Turkish * Primiparous * Spontaneous vaginal delivery planned * At the beginning of the active phase (dilatation 4 cm) * Pregnant women who agreed to participate in the research

Exclusion criteria

* Presence of a health problem in the mother during pregnancy * At risk of fetal anomaly * Having multiple pregnancy * Administering analgesic medication during labor

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Scale (VAS)through study completion, an average of 1 yearIt is a reliable and easily applicable scale accepted in the world literature. It is used to measure the values that cannot be measured numerically in the evaluation of the pain intensity and satisfaction of the patients. A minimum of 0 and a maximum of 10 points can be obtained from the scale. Additionally, higher scores indicate higher pain intensity, higher satisfaction.
Personal information formthrough study completion, an average of 1 year.It is a form that includes questions that determine socio-demographic characteristics and perception of support. The form also includes questions about the process of the birth period.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026